Crinetics Pharmaceuticals Inc (CRNX)

Cash & Equivalents

$55.50M

Quarterly · Period ending: · USD

CRNX logo

CRNX Cash & Equivalents

Latest reported$55.50M
CRNX Quarterly Cash & Equivalents (-$12.15M → $55.50M)
High-resolution chart · PNG

CRNX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
55,498,000
114,341,000
101,536,000
110,901,000
53,726,000
94,569,000
264,545,000
317,269,000
302,162,000
395,924,000
54,897,000
142,795,000
39,553,000
41,193,000
32,671,999
30,912,000
62,293,000
145,548,000
200,695,000
161,536,000
178,771,000
105,579,000
93,087,000
117,820,000
160,814,000
50,917,000
40,326,000
66,579,000
59,716,000
62,833,000
44,973,000
169,654,000
68,408,000
73,740,000
14,192,000
-12,152,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.